Clarius vs CureMetrix
Clarius makes a wireless handheld ultrasound scanner with a phone or tablet as the screen. CureMetrix makes software for mammograms. An MSK, primary care or OB practice doing point-of-care scans fits Clarius. A breast imaging facility with screening volume fits CureMetrix. A women's imaging center with ultrasound rooms and a mammography suite has a use for each.
Clarius has 12 openFDA records, six of them AI-named. Examples are Bladder AI (K232257, November 13, 2023, QIH), OB AI (K233955, June 14, 2024, IYN) and Ejection Fraction AI (K253593, March 2, 2026, QIH). The vendor marks several AI tools as available in select markets. It sells through online stores and a quote form.
CureMetrix's cmTriage cleared as K183285 on March 8, 2019 under product code QFM. Its products page says cmAssist is still under development in the US and cleared only in Brazil, and the page may be dated. Funding sources conflict, with PitchBook listing a $30M Series C on September 17, 2024 and CB Insights showing $250K raised (currency not stated for both).
Radiology · Reviewed November 2, 2026
Clarius
by Clarius Mobile Health
Wireless handheld ultrasound scanners with FDA-cleared onboard AI tools for bladder, prostate, OB and cardiac measurement.
CureMetrix
by CureMetrix
AI for mammograms: cmAngio quantifies breast arterial calcification (FDA-cleared), cmTriage prioritizes screening exams.
When to pick each one
Clarius
- Wireless handheld ultrasound with a phone display
- Bladder, prostate, OB and ejection fraction AI
- Buy Now stores and a quote request
CureMetrix
- cmTriage worklist prioritization, K183285
- cmAngio breast arterial calcification software
- Four CureMetrix products listed
Score
Each row shows points earned of points available under the published rubric.
Clarius
53of 100
CureMetrix
48of 100
| Dimension | Clarius | CureMetrix | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 12.7 / 18.2 | 12.7 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 7.8 / 7.8 | 3.9 / 7.8 | +3.9 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Clarius
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price verified. |
CureMetrix
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The homepage shows none. |
Evidence
Clarius
FDA decisions
K253593 (opens in new tab)510(k)2026-03-02
Clarius Ejection Fraction AI
K250226 (opens in new tab)510(k)2025-05-08
Clarius Median Nerve AI
K243853 (opens in new tab)510(k)2025-04-16
Clarius Prostate AI
K233955 (opens in new tab)510(k)2024-06-14
Clarius OB AI
K232257 (opens in new tab)510(k)2023-11-13
Clarius Bladder AI
Show 1 more
K222406 (opens in new tab)510(k)2023-01-23
Clarius AI
Peer-reviewed
3 PubMed records name Clarius.
- Can handheld ultrasound probes reliably measure transabdominal prostate and bladder volumes? A prospective randomized point-of-care ultrasound study. (opens in new tab)
- Artificial Intelligence-Assisted Lung Ultrasound for Pneumothorax: Diagnostic Accuracy Compared with CT in Emergency and Critical Care. (opens in new tab)
- Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology Study- Focus on Synovitis, Doppler Activity, Erosions, and Tendon Lesions. (opens in new tab)
CureMetrix
FDA decisions
K260980 (opens in new tab)510(k)2026-07-30
cmAngio V2.0
K250754 (opens in new tab)510(k)2025-04-10
cmAngio V1.6
K232367 (opens in new tab)510(k)2023-10-05
cmAngio V1.0
K183285 (opens in new tab)510(k)2019-03-08
cmTriage
Peer-reviewed
3 PubMed records name CureMetrix.
- A Novel Breast Arterial Calcification Age-Based Percentile Nomogram for the Incremental Prediction of Incidental Cardiovascular Events. (opens in new tab)
- Evaluation of an Artificial Intelligence System for Detection of Invasive Lobular Carcinoma on Digital Mammography. (opens in new tab)
- Multicenter, Multivendor Validation of an FDA-approved Algorithm for Mammography Triage. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Clarius | CureMetrix |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | n/a | US |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.